Yuan L - Search Results

1

Delivery of EZH2-shRNA with mPEG-PEI nanoparticles for the treatment of prostate cancer in vitro.

Wu Y, Yu J, Liu Y, Yuan L, Yan H, Jing J, Xu G. Wu Y, et al. Among authors: yuan l. Int J Mol Med. 2014 Jun;33(6):1563-9. doi: 10.3892/ijmm.2014.1724. Epub 2014 Apr 4. Int J Mol Med. 2014. PMID: 24714818

2

Long non-coding RNA EWSAT1 promoted metastasis and actin cytoskeleton changes via miR-24-3p sponging in osteosarcoma.

Shen D, Liu Y, Liu Y, Wang T, Yuan L, Huang X, Wang Y. Shen D, et al. Among authors: yuan l. J Cell Mol Med. 2021 Jan;25(2):716-728. doi: 10.1111/jcmm.16121. Epub 2020 Nov 22. J Cell Mol Med. 2021. PMID: 33225581 Free PMC article.

3

ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer.

Sun R, Yuan L, Jiang Y, Wan Y, Ma X, Yang J, Sun G, Zhou S, Wang H, Qiu J, Zhang L, Cheng W. Sun R, et al. Among authors: yuan l. Theranostics. 2023 Jan 5;13(2):833-848. doi: 10.7150/thno.77441. eCollection 2023. Theranostics. 2023. PMID: 36632222 Free PMC article.

4

Olaparib combined with CDK12-IN-3 to promote genomic instability and cell death in ovarian cancer.

Liang J, Zhou X, Yuan L, Chen T, Wan Y, Jiang Y, Meng H, Xu M, Zhang L, Cheng W. Liang J, et al. Among authors: yuan l. Int J Biol Sci. 2024 Aug 19;20(11):4513-4531. doi: 10.7150/ijbs.94568. eCollection 2024. Int J Biol Sci. 2024. PMID: 39247812 Free PMC article.

5

Preoperative hysteroscopy shortened progression-free survival in advanced FIGO stage in endometrial cancer: Ten year analysis.

Miao H, Zhang L, Jiang Y, Wan Y, Yuan L, Cheng W. Miao H, et al. Among authors: yuan l. Int J Gynaecol Obstet. 2024 Mar;164(3):1195-1204. doi: 10.1002/ijgo.15180. Epub 2023 Oct 5. Int J Gynaecol Obstet. 2024. PMID: 37799024

6

Elevated serum level of IL-27 and VEGF in patients with ankylosing spondylitis and associate with disease activity.

Lin TT, Lu J, Qi CY, Yuan L, Li XL, Xia LP, Shen H. Lin TT, et al. Among authors: yuan l. Clin Exp Med. 2015 May;15(2):227-31. doi: 10.1007/s10238-014-0281-x. Epub 2014 Apr 8. Clin Exp Med. 2015. PMID: 24710630

7

Interleukin-35 inhibits angiogenesis through T helper17/ Interleukin-17 related signaling pathways in IL-1β-stimulated SW1353 cells.

Yang J, Yao L, Li Y, Yuan L, Gao R, Huo R, Zhang H, Xia L, Shen H, Lu J. Yang J, et al. Among authors: yuan l. Mol Immunol. 2022 Jul;147:71-80. doi: 10.1016/j.molimm.2022.04.015. Epub 2022 Apr 30. Mol Immunol. 2022. PMID: 35504060

8

Clinical characteristics and serum CA19-9 combined with HE4 are valuable in diagnosing endometriosis-associated ovarian cancer.

Xu T, Zhang L, Jiang Y, Wan Y, Zhou S, Sun G, Cheng W, Yuan L. Xu T, et al. Among authors: yuan l. Int J Gynaecol Obstet. 2023 Aug;162(2):472-478. doi: 10.1002/ijgo.14695. Epub 2023 Feb 13. Int J Gynaecol Obstet. 2023. PMID: 36708088

9

Interleukin-35 stimulates tumor necrosis factor-α activated osteoblasts differentiation through Wnt/β-catenin signaling pathway in rheumatoid arthritis.

Li Y, Yuan L, Jiang S, Liu S, Xia L, Shen H, Lu J. Li Y, et al. Among authors: yuan l. Int Immunopharmacol. 2019 Oct;75:105810. doi: 10.1016/j.intimp.2019.105810. Epub 2019 Aug 9. Int Immunopharmacol. 2019. PMID: 31404890

10

Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.

Li XL, Lin TT, Qi CY, Yuan L, Xia LP, Shen H, Lu J. Li XL, et al. Among authors: yuan l. J Investig Med. 2013 Jun;61(5):848-51. doi: 10.2310/JIM.0b013e31828deed2. J Investig Med. 2013. PMID: 23552178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,167 results

Search Page

Filters